Medical Affairs Summit 2022 | Marcus Evans | 27 October 2022 | Encore Boston Harbor, 1 Broadway, Everett, MA 02149, USA

This summit is an invitation-only, premium Summit bringing leading medical affairs executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key medical affairs challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

Key topics:
Strengthening KOL Relationships And Acing Your Engagement Strategy
• Effectively identifying the right experts with the right information at the right time

From Aspiration To Action
• Building a digitally-empowered medical organization and mapping the future of digital innovation

Revolutionizing The Medical Affairs Function
• Transforming the role of medical affairs from communicator to a key strategic player

Capitalizing On The Pivot Towards Omnichannel
• Carefully designing your omnichannel blueprint and evaluating the future of medical omnichannel engagement

Driving Cross-Functional Collaboration Within The Medical Affairs Function
• Amplifying the relationship between clinical and commercial

Innovation In Medical Communication
• Formulating a solid medical communication plan that aligns well with the overall medical strategy

2022 Speakers

Vandana Grover, PhD
Head, Global Medical Affairs Digital Strategy & Innovation, Eisai Inc.

Mary Jessel, PhD, MBA
Vice President, Global Medical Affairs, Telix Pharmaceuticals

Kim Scalamandre-Lee
Head, Strategy and Operations, Specialty Medicines, Global Medical Affairs, GlaxoSmithKline

Eddie G M Power PhD MBA GFMD
VP, North America Medical Affairs, Hospital, Pfizer Biopharmaceuticals Group

Nami Pandit, PharmD, RPh
Senior Director, Global Medical Affairs, Sanofi

Paul O'Grady
Global Oncology Scientific Communications and Strategy Head, GlaxoSmithKline

Elizabeth Pash PhD, MS, RD, LDN
VP, Medical Affairs, Gelesis

Rushi Potdar MD MBA
Group Medical Director, Oncology, Janssen Pharmaceuticals

Janelle Landau, PhD
Worldwide Group SEC Director, Melanoma, Novartis

Deborah Braccia, PhD, MPA
Head, Global Medical Affairs Excellence, Kyowa Kirin, Inc.

Jennifer Gervasi
Executive Director, Medical Affairs, Alkermes

Todd Almarez
Director, Evidence Solutions, Neuroscience, Global Medical Affairs, Abbvie, Inc.

Teresa Kauf
Senior Director, HEOR Oncology, Alkermes

Mansi Jamindar
Director, Medical Affairs, RedHill Biopharma Inc.

Dr Eric Beresford, PharmD, BCMAS
VP, Head of Medical Affairs, Nobelpharma America, LLC

Jill Fenwick
Director, Global Field Medical Excellence & HCP Exchange, EMD Serono

Melanie Olesky
Head of Global Medical Affairs Leads, Sarepta Therapeutics

Danielle Day
Senior Medical Director, Immunology, Rare Disease, Sobi - North America

Elaine Nadeau
Senior Director, Head of Field Medical Affairs & Medical Excellence, Sobi - North America

Leona Blustein
Senior Director, Head of US Medical Affairs Operations, Idorsia Pharmaceuticals Ltd

Scott McConnell
VP, Medical Affairs, VenatoRX

Paul Rowe
VP, Head of Global Medical, Immunology, Sanofi